Lupin announces licensing deal for Ranibizumab biosimilar
Lupin will manufacture and file regulatory submissions, while Sandoz will commercialise the biosimilar across select global…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
T-cell engagers to drive immuno-oncology next growth wave: GlobalData
Bispecific T-cell engagers forecast to expand from 10% to 35% of the global immuno-oncology market by 2031 as immune checkpoint…
U.S. Tariffs on India’s pharma: Who pays, what’s at risk
The structural answer to tariff risk is not endless cost-cutting; it is moving up the value chain
Pfizer launches Pneumococcal Conjugate Vaccine for adults in India
Single-dose PCV20 approved for adults 18 years and older, covering 20 pneumococcal serotypes including both invasive and…
Eyestem Research raises $10 million to advance Eyecyte-RPE cell therapy for dry AMD
Funding to support Phase 2 clinical trial in India and preparations for US FDA Investigational New Drug application
Zydus receives USFDA approval for Diltiazem Hydrochloride Tablets in multiple strengths
Approval covers 30 mg, 60 mg, 90 mg, and 120 mg tablets for the management of chronic stable angina and angina due to coronary…
AbbVie’s upadacitinib holds potential to cement dominant place in alopecia areata with latest…
Phase III UP-AA trial data show higher response rates than current JAK inhibitors, positioning AbbVie’s upadacitinib as a…
Lupin launches Glucagon for injection USP in the United States
Product indicated for severe hypoglycaemia treatment and as a diagnostic aid during radiologic procedures in adults
Can we reduce plastics usage in pharmaceutical industry? – Think
Dr Ashok Omray highlights the widespread use of single-use plastics in pharma manufacturing and calls for scientific solutions to…
Zydus Lifesciences receives Health Canada approval for smoking cessation drug
Zydus Lifesciences secures Notice of Compliance for ZDS-Varenicline tablets in Canada, expanding its footprint in the North…